VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_15-vv-00700 Package ID: USCOURTS-cofc-1_15-vv-00700 Petitioner: E.D.D. Filed: 2015-07-06 Decided: 2020-11-02 Vaccine: MMR Vaccination date: 2012-07-24 Condition: seizure disorder Outcome: dismissed Award amount USD: AI-assisted case summary: On July 6, 2015, Eve Dineen and Daniel Dineen, as legal representatives of a minor child, E.D.D., filed a petition in the National Vaccine Injury Compensation Program. The petition alleged that E.D.D. developed a seizure disorder as a result of receiving measles, mumps, and rubella (MMR), diphtheria-tetanus-acellular pertussis (DTaP), and Hepatitis B (Hep B) vaccinations on July 24, 2012. The respondent was the Secretary of Health and Human Services. The public decision does not describe the specific onset of symptoms, any diagnostic tests performed, or treatments received. The public decision also does not name the petitioner's counsel or the respondent's counsel. On October 30, 2020, the petitioners filed a motion to dismiss their own petition, understanding that this would result in a judgment against them and end their rights in the Vaccine Program. They stated their intention to preserve their right to file a civil action in the future. The Special Master granted the motion to dismiss for insufficient proof, and judgment was entered accordingly. The respondent reserved the right to question the good faith and reasonable basis of the claim regarding fees and costs but otherwise did not oppose the motion. The public decision does not detail the Special Master's reasoning beyond granting the motion for insufficient proof. Theory of causation field: Petitioners alleged that minor child E.D.D. developed a seizure disorder as a result of receiving MMR, DTaP, and Hep B vaccinations on July 24, 2012. The public decision states that the record did not contain persuasive evidence that E.D.D. suffered a Table Injury or that the vaccines caused the seizure disorder. Petitioners filed a motion to dismiss their petition for insufficient proof, which was granted by Special Master Thomas L. Gowen on November 2, 2020. The respondent, Secretary of Health and Human Services, did not oppose the motion to dismiss, reserving the right to question fees and costs. The public decision does not describe the specific mechanism of causation, name any experts, or provide a breakdown of any award, as the case was dismissed. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_15-vv-00700-2 Date issued/filed: 2020-11-23 Pages: 2 Docket text: PUBLIC DECISION (Originally filed: 11/2/20) regarding 104 DECISION of Special Master Signed by Special Master Thomas L. Gowen. (kb) Service on parties made. -------------------------------------------------------------------------------- Case 1:15-vv-00700-UNJ Document 105 Filed 11/23/20 Page 1 of 2 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: November 2, 2020 * * * * * * * * * * * * * EVE DINEEN and DANIEL * DINEEN, as legal representatives of a * UNPUBLISHED minor child, E.D.D., * * No. 15-700V Petitioners, * v. * Special Master Gowen * SECRETARY OF HEALTH * Motion for Decision Dismissing Claim; AND HUMAN SERVICES, * Measles-Mumps-Rubella (MMR); * Diphtheria-Tetanus-acellular Pertussis Respondent. * (DTaP); Hepatitis B (Hep B); Seizure * Disorder. * * * * * * * * * * * * * Mark T. Sadaka, Mark T. Sadaka LLC, Englewood, NJ, for petitioners. Ryan D. Pyles, United States Department of Justice, Washington, DC, for respondent. DECISION1 On July 6, 2015, Eve Dineen and Daniel Dineen, as legal representatives of a minor child E.D.D. (“petitioners”), filed a petition in the National Vaccine Injury Compensation Program.2 Petition (ECF No. 1). Petitioners alleged that E.D.D. developed a seizure disorder as a result of receiving measles, mumps, and rubella (“MMR”), diphtheria-tetanus-acellular pertussis (“DTaP”), and Hepatitis B (“Hep B”) vaccinations on July 24, 2012. Id. The information in the record, does not establish entitlement to compensation. 1 Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this opinion contains a reasoned explanation for the action in this case, I am required to post it on the website of the United States Court of Federal Claims. The court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. This means the opinion will be available to anyone with access to the Internet. Before the opinion is posted on the court’s website, each party has 14 days to file a motion requesting redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). An objecting party must provide the court with a proposed redacted version of the opinion. Id. If neither party files a motion for redaction within 14 days, the opinion will be posted on the court’s website without any changes. Id. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to -34 (2012) (Vaccine Act or the Act). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. Case 1:15-vv-00700-UNJ Document 105 Filed 11/23/20 Page 2 of 2 On October 30, 2020, petitioners filed a motion for a decision dismissing the petition. Petitioners’ Motion (“Pet. Mot.”) (ECF No. 103). Petitioners understand that a decision dismissing their petition will result in a judgment against them. Id. at 1. They have been advised that such a judgment will end all of their rights in the Vaccine Program. Id. Petitioners understand that they may apply for fees and costs once their case is dismissed and judgment is entered against them. Id. at ¶ 4. Petitioners’ counsel has contacted respondent’s counsel regarding respondent’s position on this motion and understands that respondent expressly reserves the right, pursuant to 42 U.S.C. § 300aa-15(e), to question the good faith and reasonable basis of the claim and to oppose, if appropriate, the application for fees and costs. Id. Respondent otherwise does not oppose this motion. Id. Petitioners do intend to protect their rights to file a civil action in the future. Id. at 2. Therefore, pursuant to 42 U.S.C. § 300aa- 21(a)(2), they intend to elect to reject the Vaccine Program judgment against them and elect to file a civil action. Id. To receive compensation in the Vaccine Program, a petitioner has the burden of proving either: (1) a “Table Injury,” i.e., an injury beginning within a specified period of time following receipt of a corresponding vaccine listed on the Vaccine Injury Table (a “Table injury”) or (2) an injury that was caused-in-fact by a covered vaccine. 42 U.S.C. §§ 300aa-13(a)(1)(A); 11(c)(1). Here, an examination of the record does not contain persuasive evidence that E.D.D. suffered a “Table Injury”. Thus, petitioners are limited to alleging causation-in-fact. The record does not contain persuasive evidence that E.D.D.’s injury was caused in fact or in any way related to the vaccines which he received. Thus, petitioners’ motion is GRANTED. This matter is DISMISSED for insufficient proof. The Clerk of the Court shall enter judgment accordingly.3 IT IS SO ORDERED. s/Thomas L. Gowen Thomas L. Gowen Special Master 3 Entry of judgment is expedited by each party’s filing notice renouncing the right to seek review. Vaccine Rule 11(a). 2